Skip to main content

alpha This is a new site, your feedback will help us to improve it.

Lutathera for neuroendocrine tumours

Published on 07 August 2020

Lutathera therapy treatment for neuroendocrine tumours (NETs) is provided at the Beatson West of Scotland Cancer Centre in Glasgow.

What is the Lutathera Therapy Service?

The service provides in-patient and follow-up treatment to people with small bowel NETs that are somatostatin receptor (SSR) positive. Lutathera therapy slows down the growth of tumours, or prevents them from growing altogether.

After each treatment, a post-therapy nuclear medicine scan assesses distribution of the Lutathera. Follow-up care will continue to be provided jointly by the patient’s local team and the national service.

Lead clinician

Professor Nick Reed, Consultant Clinical Oncologist, NHS Greater Glasgow & Clyde

NSD contact

Programme Manager, Joanne Milne-Toner – joanne.milne-toner@nhs.scot – 0131 2756558

Address

Beatson West of Scotland Cancer Centre
1053 Great Western Road
Glasgow
G12 0YN